Drug Therapy

1. Treatment-related acute myeloid leukemia with 11q23 translocation following treatment with fludarabine, cyclophosphamide and rituximab.

Author
Martin-Salces M; Canales MA; de Paz R; Hernandez-Navarro F;
Institution
Journal
Leuk Res. 2008 Jan;32(1):199-200. Epub 2007 Sep 17.

2. Combination chemotherapy with low-dose cytarabine, homoharringtonine, and granulocyte colony-stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia.

Author
Zhang WG; Wang FX; Chen YX; Cao XM; He AL; Liu J; Ma XR; Zhao WH; Liu SH; Wang JL;
Institution
Department of Hematology and Oncology, The Second Affiliated Hospital, Xi'an JiaoTong University, Xi'an, People's Republic of China. zhangwanggang2003@yahoo.com
Journal
Am J Hematol. 2008 Mar;83(3):185-8.
Abstract URL
Click here to view abstract

3. A new intensive induction schedule, including high-dose Idarubicin, high-dose Aracytin and Amifostine, in older AML patients: feasibility and long-term results in 42 patients.

Author
Olivieri A; Capelli D; Troiani E; Poloni A; Montanari M; Offidani M; Discepoli G; Leoni P;
Institution
Department of Hematology, Medical School, University of Ancona, Ancona, Italy. attilo.olivieri@ospedalesancarlo.it
Journal
Exp Hematol. 2007 Jul;35(7):1074-82.
Abstract URL
Click here to view abstract

4. Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group.

Author
Wierzbowska A; Robak T; Pluta A; Wawrzyniak E; Cebula B; Holowiecki J; Kyrcz-Krzemien S; Grosicki S; Giebel S; Skotnicki AB; Piatkowska-Jakubas B; Kuliczkowski K; Kielbinski M; Zawilska K; Kloczko J; Wrzesien-Kus A;
Institution
Department of Hematology, Medical University, Lodz, Poland.
Journal
Eur J Haematol. 2008 Feb;80(2):115-26. Epub 2007 Dec 11.
Abstract URL
Click here to view abstract

5. Tipifarnib in acute myeloid leukemia.

Author
Burnett AK; Kell J;
Institution
Department of Haematology, School of Medicine, Cardiff University, Cardiff, UK. BurnettAK@Cardiff.ac.uk
Journal
Drugs Today (Barc). 2007 Nov;43(11):795-800.
Abstract URL
Click here to view abstract

6. Neutropenic fever and severe sepsis in adult acute myeloid leukemia (AML) patients receiving intensive chemotherapy: Causes and consequences.

Author
Hamalainen S; Kuittinen T; Matinlauri I; Nousiainen T; Koivula I; Jantunen E;
Institution
Department of Medicine, Kuopio University Hospital, Kuopio, Finland.
Journal
Leuk Lymphoma. 2008 Mar;49(3):495-501.
Abstract URL
Click here to view abstract

7. Recombinant granulocyte-colony stimulating factor as treatment for poor prognosis oligoblastic acute myeloid leukemia in elderly patients.

Author
Pelizzari AM; Drera M; D'Adda M; Ungari M; Marocolo D; Facchetti F; Bellotti D; Barlati S; Rossi G;
Institution
Divisione Ematologia, Spedali Civili P. le Spedali Civili, 1 25123 Brescia, Italy.
Journal
Haematologica. 2007 Jan;92(1):106-9.
Abstract URL
Click here to view abstract

8. The outcome of intensive induction therapy in patients >/=70 years with acute myeloid leukemia.

Author
Gupta V; Xu W; Keng C; Alibhai SM; Brandwein J; Schimmer A; Schuh A; Yee K; Minden MD;
Institution
1Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada.
Journal
Leukemia. 2007 Mar 8;.

9. Gemtuzumab ozogamicin with cytarabine and mitoxantrone as a third-line treatment in a poor prognosis group of adult acute myeloid leukemia patients: a single-center experience.

Author
Specchia G; Pastore D; Carluccio P; Spinosa G; Giannoccaro M; Rizzi R; Mestice A; Liso V;
Institution
Hematology Section, DAP, University of Bari, Piazza G. Cesare 11, 70124, Bari, Italy, g.specchia@ematba.uniba.it.
Journal
Ann Hematol. 2007 Jun;86(6):425-8. Epub 2007 Mar 16.
Abstract URL
Click here to view abstract

10. Effect of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on the outcome of elderly patients with acute myeloid leukemia.

Author
Qian SX; Li JY; Tian T; Shen YF; Jiang YQ; Lu H; Wu HX; Zhang SJ; Xu W;
Institution
Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, 300 Guangzhou Road, Nanjing 210029, China.
Journal
Leuk Res. 2007 Apr 7;.
Abstract URL
Click here to view abstract

11. Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia.

Author
Etienne A; Esterni B; Charbonnier A; Mozziconacci MJ; Arnoulet C; Coso D; Puig B; Gastaut JA; Maraninchi D; Vey N;
Institution
Department of Hematology, Paoli-Calmettes Institute, Marseille, France.
Journal
Cancer. 2007 Apr 1;109(7):1376-83.
Abstract URL
Click here to view abstract